Cargando…
Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections
New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in infants during their first RSV season. The lack of...
Autores principales: | Weil-Olivier, Catherine, Salisbury, David, Navarro-Alonso, José Antonio, Tzialla, Chryssoula, Zhang, Yan, Esposito, Susanna, Midulla, Fabio, Tenenbaum, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190199/ https://www.ncbi.nlm.nih.gov/pubmed/37193673 http://dx.doi.org/10.1080/21645515.2023.2209000 |
Ejemplares similares
-
Respiratory syncytial virus-associated hospitalization in children aged <2 years in Spain from 2018 to 2021
por: Gea-Izquierdo, Enrique, et al.
Publicado: (2023) -
RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines
por: Limaye, Rupali J., et al.
Publicado: (2023) -
RSV awareness, risk perception, causes, and terms: Comment
por: Wiwanitkit, Somsri, et al.
Publicado: (2023) -
Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020) -
Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
por: Scagnolari, Carolina, et al.
Publicado: (2012)